TARA SWAN: Open Payments
NPI 1982773586 · CARROLLTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,411 in 165 payments from 16 companies in 2025. Trend: 2023 $410 · 2024 $1,355 · 2025 $1,411
Food & beverage: $1,411
| Company | Payments | Amount |
|---|---|---|
| MIMEDX Group, Inc. | 138 | $857 |
| Astellas Pharma US Inc | 4 | $105 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $94 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $51 |
| AstraZeneca Pharmaceuticals LP | 3 | $45 |
| Lundbeck LLC | 2 | $36 |
| ABBVIE INC. | 2 | $33 |
| SANOFI-AVENTIS U.S. LLC | 1 | $28 |
| Dexcom, Inc. | 1 | $25 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
Products named: Veozah, REXULTI, CAPLYTA, AIRSUPRA, OFEV, QULIPTA, TZIELD, Dexcom G6 Transmitter.
Industry payments across MO — which companies pay providers there.
